Accession Number: | 0001104659-20-038879 |
Date: | 2020-03-24 |
Issuer: | APREA THERAPEUTICS, INC. (APRE) |
Original Submission Date: |
ABRAHMSEN LARS B.
535 BOYLSTON STREET
BOSTON, MA 02116
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 35.5 | 2020-03-24 | deemed execution date | A | 31,600 (a) | 2030-03-24 | common stock 31,600 | $35.50 | 31,600 | direct |
ID | footnote |
---|---|
f1 | twenty-five percent of these options vest on march 24, 2021, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions. |